22 September, 2016 by The TZ Newswire Staff Comments Off on Goldman: Stocks to Buy, Whoever Wins the Election (CVS, NOC)
Goldman: Stocks to Buy, Whoever Wins the Election (CVS, NOC)
Whoever moves into the White House in January, Goldman sees increased government spending and corporate tax reform boosting these firms. But watch out for a higher minimum wage.
22 September, 2016 by The TZ Newswire Staff Comments Off on Market Extra: Buy bonds, buy stocks, sell risk, blame the Fed
Market Extra: Buy bonds, buy stocks, sell risk, blame the Fed
It’s happening—again.
22 September, 2016 by The TZ Newswire Staff Comments Off on The Wall Street Journal: Airbnb raises $850 million in funding round that values it at $30 billion
The Wall Street Journal: Airbnb raises $850 million in funding round that values it at $30 billion
Google Capital and Technology Crossover Ventures lead the Airbnb deal.
read more
22 September, 2016 by The TZ Newswire Staff Comments Off on Westfield sues yet another WTC mall tenant for not moving in
Westfield sues yet another WTC mall tenant for not moving in
Westfield is suing a fifth retail tenant for not taking space at the shopping complex at the World Trade Center. The Australian real estate firm claims Edward Beiner owes $2.5 million for “defaulting” on its seven-year lease. The luxury Miami-based eyewear retailer informed Westfield in June that it would not be taking possession of the 658-square-foot space it had leased. The retailer said it would not be ready in time for the August opening date … [more]
22 September, 2016 by The TZ Newswire Staff Comments Off on GW Pharmaceuticals in 5 Charts
GW Pharmaceuticals in 5 Charts
GW Pharmaceuticals (NASDAQ: GWPH) has come a long ways since gaining EU approval for Sativex, which treats muscle spasms in multiple sclerosis patients, but has been commercially disappointing with sales that would be a rounding error for many large biotechs. Here are five charts that show the current state of the biotech focused on making drugs from marijuana.
